Dr. Maria Cristina Riascos is a PGY-1 resident at the Mass General Brigham pathology program. She graduated from Venezuela’s Central University in 2018 and relocated to the USA to pursue further training. She became a USA-licensed MD and then developed a special interest in clinical, translational, and basic science research. As a member of both the Radiology (Jin Lab) and Surgery (Fahey Lab) research teams at Weill Cornell, she expanded her knowledge on pathology and genomic profiling of papillary and anaplastic thyroid cancer and worked on designing animal tumor models for the development of CART cell therapies for various cancer types. Currently, she is undergoing pathology residency training at MGB with a particular interest in molecular, genetic, and endocrine pathology.
Dr. Maria Cristina Riascos is a PGY-1 resident at the Mass General Brigham pathology program. She graduated from Venezuela’s Central University in 2018 and relocated to the USA to pursue further training. She became a USA-licensed MD and then developed a special interest in clinical, translational, and basic science research. As a member of both the Radiology (Jin Lab) and Surgery (Fahey Lab) research teams at Weill Cornell, she expanded her knowledge on pathology and genomic profiling of papillary and anaplastic thyroid cancer and worked on designing animal tumor models for the development of CART cell therapies for various cancer types. Currently, she is undergoing pathology residency training at MGB with a particular interest in molecular, genetic, and endocrine pathology.